Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, discusses the importance of oncology practices participating in alternative payment models (APMs).
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, discusses the importance of oncology practices participating in alternative payment models (APMs).
Transcript:
What were some of the highlights from your panel on payment models?
So, I was fortunate enough to moderate a panel today on alternative payment models (APMs). We had a representative from Moffitt Cancer Center, a representative from the Memorial Healthcare System, and a representative from Florida Cancer [Specialists]. So that’s great because those are 3 very different practice settings all of whom are knee deep in APMs.
Two of the 3 are involved in the Oncology Care Model (OCM). Moffitt is not in the OCM because they’re a [prospective payment system] PPS-exempt hospital and were not allowed to participate.
But I think the take home messages were that overall the OCM has been a positive experience for the 2 groups that participated. They’ve learned a lot about how to optimize care delivery, they’ve looked at where they could improve care, they looked at the opportunities to improve the patient experience, and at the same time [were] cognizant of cost.
So, I would say one of the important takeaways was that for practices who were in the OCM, they would do it again, and that’s important. The second thing was that all 3 groups are participating in other APMs, and that is really good news. I think when the OCM was launched it was somewhat disappointing that so few commercial payers chose to participate. I was at Aetna at the time and we did choose to participate, but very few commercial payers did choose to participate.
Nonetheless, all three groups that we had on our panel today are participating in APMs, and that’s good news because I believe that the knowledge gained, for example, in the OCM is transferable to these other models, and our panelists said as much.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More